`Remarkable’: CAR T therapy for CLL/SLLJune 8, 2023CLLB Cell LymphomaNon-Hodgkin LymphomaCellular Therapy
The enemy of carcinogenic fumes is my friendly begoniaJune 8, 2023LOTMEMixed TopicsBusiness of Medicine
PMBCL: Postremission, patients may safely skip radiationJune 6, 2023B Cell LymphomaDLBCLNon-Hodgkin Lymphoma
Medicaid expansion closing racial gap in GI cancer deathsJune 4, 2023Diversity in MedicinePatient & Survivor CareBusiness of Medicine
Cross-border U.S.-Mexican collaboration drives up ALL survivalJune 4, 2023ALLPatient & Survivor CarePediatricsDiversity in Medicine
Blood cancer patient takes on bias and ‘gaslighting’May 31, 2023Hodgkin LymphomaDiversity in MedicinePatient & Survivor CareMixed Topics
States move to curb insurers’ prior authorization requirements as federal reforms lagMay 26, 2023Business of Medicine
People still want their medical intelligence in human formMay 25, 2023LOTMEMixed TopicsBusiness of Medicine
Focus of new ASH VTE guidelines: Thrombophilia testingMay 23, 2023Bleeding DisordersThrombosisMixed Topics
